Mehdi Mohammadzadeh
Overview
Explore the profile of Mehdi Mohammadzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rashidi F, Mohammadzadeh M, Abdolmaleki A, Asadi A, Sheikhlou M
J Cardiovasc Thorac Res
. 2024 Apr;
16(1):28-37.
PMID: 38584661
Introduction: The issues associated with the limitation of appropriate autologous vessels for vascular reconstruction via bypass surgery highlight the need for new alternative strategies based on tissue engineering. The present...
2.
Mousavi A, Zare H, Asadian A, Mohammadzadeh M
Iran J Pharm Res
. 2022 Sep;
21(1):e127039.
PMID: 36060917
Background: Product life cycle (PLC) refers to the time ranging from when a product is introduced into the market to when it is taken off the shelves. The PLC management...
3.
Alizadeh Z, Khodabakhsh R, Mohammadzadeh M, Pazhang Y, Mohammadi S
J Cancer Res Ther
. 2022 Apr;
18(1):200-208.
PMID: 35381784
Objective: Most studies suggest that dose-specific radiation regimens are essential for optimal induction of cancer cell response. This study focused on determining β-radiation-absorbed dose (rad) effects on the cell viability,...
4.
Akbarbegloo M, Sanaeefar M, Majid P, Mohammadzadeh M
Health Soc Care Community
. 2021 Jun;
30(1):264-274.
PMID: 34180102
Due to the onset peak of COVID-19, as well as a shortage of human resources, physical environment, protective and medical equipment in hospitals, many patients with mild to moderate symptoms...
5.
Baghay Esfandyari Y, Doustvandi M, Amini M, Baradaran B, Zaer S, Mozammel N, et al.
Reprod Sci
. 2021 Feb;
28(7):2036-2049.
PMID: 33569751
Cisplatin-based chemotherapy is commonly used for cervical cancer treatment. However, the development of chemoresistance is considered the main obstacle to the effectiveness of this therapeutic agent. MicroRNAs are illustrated to...
6.
Mohammadzadeh M, Hoseini Z, Derafshi H
Procedia Comput Sci
. 2020 Apr;
120:23-30.
PMID: 32288897
Nowadays Health care industry has a significant growth in using data mining techniques to discover hidden information for effective decision making. Huge amount of healthcare data is suitable to mine...
7.
Zeinali F, Rajabzadeh Ghatari A, Mohammadzadeh M, Mojibian F
Iran J Pharm Res
. 2020 Mar;
18(4):2216-2225.
PMID: 32184886
Unsteady increase in using pharmaceutical opioids is a phenomenon that has existed in human societies for a long time. Furthermore, the ever-growing trend of addiction to opioids affects communities in...
8.
Aalaei S, Mohammadzadeh M, Pazhang Y
EXCLI J
. 2019 Oct;
18:619-630.
PMID: 31611745
Nitroglycerin (NG), a nitric oxide donor, and valproic acid (VPA), an inhibitor of histone deacetylases, have impressive effects on numerous cancer cell lines. This study intended to evaluate synergistic effects...
9.
Abolfazli S, Mohammadzadeh M, Peiravian F, Zonoozi J, Sharifnia H, Vasheghani A
Iran J Pharm Res
. 2019 May;
18(1):531-545.
PMID: 31089387
This study investigated the relationship between main dimensions in the strategy-making process, environmental complexity, and performance in pharmaceutical companies of Iran. Results argue that pharmaceutical companies like other industries place...
10.
Mohammadzadeh M, Derafshi H, Ghari T
Iran J Public Health
. 2018 Dec;
47(10):1575-1582.
PMID: 30524989
Background: One of the major causes of liver-related mortality and morbidity is Hepatitis C Virus (HCV) infection. It is also one of the reasons behinds of chronic liver disease and...